Company Search:
Advanced Search
Sponsored Links
Kancera AB Company Snapshot
Kancera AB operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other pharmaceutical manufacturers in Europe: Pharnext SA of FRANCE (2019 sales of 252,773.00 Euros [US$294,606.93 ] of which 100% was The conduct of research and development ), Oasmia Pharmaceutical AB (1.98 million Swedish Kronor [US$219,502.80 ] of which 65% was Sales of goods), and Provexis PLC which is based in UNITED KINGDOM (£322,189.00 [US$409,908.18 ] ).

Sales Analysis. Sales increased substantially in 2019: Kancera AB reported sales of SEK 3.22 million (US$356.53 thousand) for the year ending December of 2019. This represents an increase of 798.3% versus 2018, when the company's sales were SEK 358,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kancera AB
  Stock Performance Chart for Kancera AB
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 4.25
(Figures in Swedish Kronor)
1 Week 15.5%   13 Weeks 18.4%  
4 Weeks 102.9%   52 Weeks 475.7%  
Kancera AB Key Data:
  Ticker: KAN Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 3,216,000
(Year Ending Jan 2020).
Employees: 20
  Currency: Swedish Kronor Market Cap: 1,854,719,622
  Fiscal Yr Ends: December Shares Outstanding: 436,404,617
  Share Type: AKTIER Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.